http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30172901

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 64
issn 1465-542X
1465-5411
issueIdentifier 5
pageRange r753-64
publicationName Breast cancer research : BCR
startingPage r753
bibliographicCitation Yamashita H, Nishio M, Kobayashi S, Ando Y, Sugiura H, Zhang Z, Hamaguchi M, Mita K, Fujii Y, Iwase H. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer. Breast Cancer Res. 2005;7(5):R753–64. PMID: 16168121; PMCID: PMC1242143.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7b41a5df3fc173c05951f2a6624abdc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cca99e43174d17cfe51274d9957fe1e4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba2a8f9a0372c5d2baf459b05fac360f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa290908f9ccdcf9ffa567030fbe32d8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e1b249dfcf55087b5b0a22738d6bf520
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1204cc06f54f38dd117f4c97ff6bba5c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_077757dc93e33d4a85833c71c84ddd07
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82e30cdb0b17d310517d10064383d670
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_287d2dda6a8d885281145911d2d46329
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c16a0319485019a45dd07268939a728
date 2005-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/16168121
https://pubmed.ncbi.nlm.nih.gov/PMC1242143
https://doi.org/10.1186/bcr1285
isPartOf https://portal.issn.org/resource/ISSN/1465-5411
https://portal.issn.org/resource/ISSN/1465-542X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21884
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer
discusses http://id.nlm.nih.gov/mesh/M0018613
http://id.nlm.nih.gov/mesh/M0280632
http://id.nlm.nih.gov/mesh/M0265136
http://id.nlm.nih.gov/mesh/M0007772
http://id.nlm.nih.gov/mesh/M0016735
http://id.nlm.nih.gov/mesh/M0028300
http://id.nlm.nih.gov/mesh/M0007549
http://id.nlm.nih.gov/mesh/M0028048
http://id.nlm.nih.gov/mesh/M0018641
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_26e3b3a0ea8ee6116067a3b73abe7e5c
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6d00df506eed78175933b5ecde287c64
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128364298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128643942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129138006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136033793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129888770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127819769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129308074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129773695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129506098
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127591104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128215673
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853

Total number of triples: 61.